First Time Loading...
T

Talis Biomedical Corp
NASDAQ:TLIS

Watchlist Manager
Talis Biomedical Corp
NASDAQ:TLIS
Watchlist
Price: 8.91 USD -0.94% Market Closed
Updated: Jun 16, 2024
Have any thoughts about
Talis Biomedical Corp?
Write Note

Talis Biomedical Corp
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Talis Biomedical Corp
Stock-Based Compensation Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
T
Talis Biomedical Corp
NASDAQ:TLIS
Stock-Based Compensation
$4.4m
CAGR 3-Years
6%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Stock-Based Compensation
$257m
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Stock-Based Compensation
$241m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Stock-Based Compensation
$218m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Stock-Based Compensation
$606.3m
CAGR 3-Years
14%
CAGR 5-Years
17%
CAGR 10-Years
13%

See Also

What is Talis Biomedical Corp's Stock-Based Compensation?
Stock-Based Compensation
4.4m USD

Based on the financial report for Dec 31, 2023, Talis Biomedical Corp's Stock-Based Compensation amounts to 4.4m USD.

What is Talis Biomedical Corp's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
45%

Over the last year, the Stock-Based Compensation growth was -19%. The average annual Stock-Based Compensation growth rates for Talis Biomedical Corp have been 6% over the past three years , 45% over the past five years .